Synergistic antitumor activity of sorafenib and artesunate in hepatocellular carcinoma cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synergistic antitumor activity of sorafenib and artesunate in hepatocellular carcinoma cells
Authors
Keywords
-
Journal
ACTA PHARMACOLOGICA SINICA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-04-16
DOI
10.1038/s41401-020-0395-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The anti-malarial drug artesunate causes cell cycle arrest and apoptosis of triple-negative MDA-MB-468 and HER2-enriched SK-BR-3 breast cancer cells
- (2019) Anna L. Greenshields et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Propensity score analysis of artesunate versus quinine for severe imported Plasmodium falciparum malaria in France
- (2019) N Elket et al. CLINICAL INFECTIOUS DISEASES
- Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction
- (2019) Fasiha Kanwal et al. GASTROENTEROLOGY
- Targeting autophagy enhances the anticancer effect of artemisinin and its derivatives
- (2019) Xin Sun et al. MEDICINAL RESEARCH REVIEWS
- Artesunate shows potent anti-tumor activity in B-cell lymphoma
- (2018) Thea Kristin Våtsveen et al. Journal of Hematology & Oncology
- The Antimalarial Drug Artesunate Attenuates Cardiac Injury in A Rodent Model of Myocardial Infarction
- (2018) Areeg I. Khan et al. SHOCK
- Silicon dioxide nanoparticles induce COX-2 expression through activation of STAT3 signaling pathway in HaCaT cells
- (2018) Juthika Kundu et al. TOXICOLOGY IN VITRO
- Cinobufacini inhibits epithelial-mesenchymal transition of human hepatocellular carcinoma cells through c-Met/ERK signaling pathway
- (2018) Fanghua Qi et al. BioScience Trends
- Differential expression of APE1 in hepatocellular carcinoma and the effects on proliferation and apoptosis of cancer cells
- (2018) Zhipeng Sun et al. BioScience Trends
- Update review of skin adverse events during treatment of lung cancer and colorectal carcinoma with epidermal growth receptor factor inhibitors
- (2018) Yanmei Peng et al. BioScience Trends
- From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world
- (2017) Dimitrios Dimitroulis et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The clinical management of hepatocellular carcinoma worldwide: A concise review and comparison of current guidelines from 2001 to 2017
- (2017) Peipei Song et al. BioScience Trends
- Impact of current staging systems on treatment strategy for HBV-related hepatocellular carcinoma
- (2016) Xiaopeng Yan et al. CANCER LETTERS
- Artesunate as an Anti-Cancer Agent Targets Stat-3 and Favorably Suppresses Hepatocellular Carcinoma
- (2016) M. Ilamathi et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- A Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal Cancer
- (2015) Sanjeev Krishna et al. EBioMedicine
- ROS Function in Redox Signaling and Oxidative Stress
- (2014) Michael Schieber et al. CURRENT BIOLOGY
- Therapeutic effects of artesunate in hepatocellular carcinoma
- (2014) Yves-Paul Vandewynckel et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Signal transduction by reactive oxygen species
- (2011) Toren Finkel JOURNAL OF CELL BIOLOGY
- Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma
- (2011) Wei-Tien Tai et al. JOURNAL OF HEPATOLOGY
- Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration
- (2011) Carrie A Morris et al. MALARIA JOURNAL
- Hepatocyte IKKβ/NF-κB Inhibits Tumor Promotion and Progression by Preventing Oxidative Stress-Driven STAT3 Activation
- (2010) Guobin He et al. CANCER CELL
- Pharmacogenomic Identification of c-Myc/Max-Regulated Genes Associated with Cytotoxicity of Artesunate towards Human Colon, Ovarian and Lung Cancer Cell Lines
- (2010) Serkan Sertel et al. MOLECULES
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation